Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Sponsor: Abbott Medical Devices
Listed as NCT02173379, this NA trial focuses on Coronary Artery Disease and Coronary Artery Stenosis and remains completed. Sponsored by Abbott Medical Devices, it has been updated 20 times since 2014, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
20 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Nov 2023 — Jul 2024 [monthly]
Completed NA
-
Sep 2022 — Nov 2023 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 15 earlier versions
-
May 2022 — Sep 2022 [monthly]
Active Not Recruiting NA
-
Apr 2022 — May 2022 [monthly]
Active Not Recruiting NA
-
Jun 2021 — Apr 2022 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Jun 2021 [monthly]
Active Not Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Nov 2020 — Dec 2020 [monthly]
Active Not Recruiting NA
-
Dec 2019 — Nov 2020 [monthly]
Active Not Recruiting NA
-
Nov 2019 — Dec 2019 [monthly]
Active Not Recruiting NA
-
Dec 2018 — Nov 2019 [monthly]
Active Not Recruiting NA
-
Oct 2018 — Dec 2018 [monthly]
Active Not Recruiting NA
-
Aug 2018 — Oct 2018 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting NA
-
Aug 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Jul 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
For direct contact, visit the study record on ClinicalTrials.gov .